Brian Newman : Yeah, it’s a great question. So the GRI, as you know, was 6.9%. And with the service rates, we’ll keep a decent amount of that. The guide for RPP that we’re building in our base case is mid-single digit for RPP, and that is facing two headwinds off of that number. You’ve got product mix and fuel, which are each combined, about 150 to 200 basis points off of that mid-single digit. So that’s how we’re thinking about it. And the product mix is really less air, more sure post, so a shift in the product mix. And then the fuel component, fuel is not going to have a big net impact to the business in 2023. But obviously, there’s a cost component versus a revenue component.
Todd Fowler : Got it. That’s helpful. Thanks a lot.
Operator: Our next question comes from the line of Allison Poliniak of Wells Fargo. Please go ahead.
Allison Poliniak: Hi, good morning. I just want to turn to health care. You’re quickly approaching sort of that original target of $10 billion in revenue there. Obviously, investing some more this year in that vertical. Is there a way to think of what kind of outgrowth you’re seeing there? Sort of what’s the base market case growth for health care this year versus what you guys are seeing or growing above? Just any color there.
Carol Tome : Well, I think Kate is here. And Kate, it would be great if you could just take that question, please.
Kate Gutmann : Yeah, absolutely. Thank you, Allison. So we’ve really been able to grow healthcare beyond even lapping the vaccine distribution that we did over $1 billion. And that was because with that service that we’re delivering and the capability around the globe, we’re actually selling more into biologics and some of the developing treatments. So that continues to fuel us for the future growth. We’ve seen double-digit growth, and we’re planning for double-digit growth this year as well with very strong margins.
Allison Poliniak: Great. Thank you.
Operator: Our next question comes from the line of Jordan Alliger of Goldman Sachs. Please go ahead.
Jordan Alliger : Yeah, hi. Good morning. Knowing that the SMB penetration continues to be an important part of the strategy, just sort of curious in an environment that’s tougher, does it get more difficult to penetrate them? And do you find it maybe when you do, they’re sort of trading down in services? Just sort of curious, especially given your large customer will continue to sort of shrink over the coming years. Thanks.
Carol Tome : Well, we’ve been investing in the experience because we think that’s the way to not only grow, but to keep that very important customer. And I couldn’t be more proud of what we — the team has delivered in this regard. So if you think about customer journeys, if you will, there are three really big pain points. One was negotiate value. And that’s why we’re so thrilled with deal manager because deal manager is a huge home run. Iur win rate is 22% higher than we thought it would be with better revenue quality and the customers are happy because they’re getting a deal with us within seven days. It used to take weeks. So negotiated value is an important part of continuing to serve this customer. Another is reroute a package.
We had some issues systemically that needed to be addressed, and we fixed that. So now we can reroute a package. And then finally, resolving a claim. Here, we had a broken link. So when you had a claim, it was not a good experience for our customers. And we’ve seen our net promoter score in this area alone improve dramatically. And the speed to pay, if a claim needs to pay, has improved by 10 days. So we continue to lean into the experience. And Brian, I know you want to add something here.
